Table 1. Patient demographics (n = 48).

Patient descriptor	N ± SD, N (%) or range
Age at diagnosis†	33.6 ± 16.1
Symptom length in years before diagnosis	10.8 ± 9.3
Male	33 (69%)
White	44 (96%)
Private insurance	37, (82%)
Atopic disease diagnosis	27, (56%)
Food allergy	16, (33%)
Length of follow-up in patient months
All patients	13.2 ± 11.8; 1.8-56.3
Time to first follow-up biopsy	6.2 ± 8.1; 1.4-42.0
Time to final available biopsy	17.0 ± 12.3; 4.2-56.3
Initial compounded budesonide dose in milligrams	2.4 ± 0.9; 1 - 6
Final compounded budesonide dose	2.2 ± 1.3; 0.5 - 4
Concurrent food elimination diet‡	8 (17%)

^†SD = standard deviation;

^‡Compounded budesonide was added to a targeted food elimination diet in 8 patients. The targeted elimination diets varied from a single food removed (i.e. low-heat eggs) to 8 separate foods removed from a patient's diet (i.e. nuts, chocolate, soy, oats, barley, sesame, and shellfish, coconut, peaches, and apples).In 4 of these patients, a portion of the eliminated foods was a trigger of immediate-allergic food allergies.